LegoChem Biosciences, Inc. (141080.KQ)

KRW 96700.0

(-6.84%)

Net Income Summary of LegoChem Biosciences, Inc.

LegoChem Biosciences, Inc.'s latest annual net income in 2023 was -73.7 Billion KRW , down -63.45% from previous year.
LegoChem Biosciences, Inc.'s latest quarterly net income in 2024 Q2 was -7.44 Billion KRW , down -179.08% from previous quarter.
LegoChem Biosciences, Inc. reported an annual net income of -45.09 Billion KRW in 2022, down -92.77% from previous year.
LegoChem Biosciences, Inc. reported an annual net income of -23.39 Billion KRW in 2021, down -234.82% from previous year.
LegoChem Biosciences, Inc. reported a quarterly net income of 9.41 Billion KRW for 2024 Q1, up 158.29% from previous quarter.
LegoChem Biosciences, Inc. reported a quarterly net income of -17.74 Billion KRW for 2023 Q1, up 30.41% from previous quarter.

Annual Net Income Chart of LegoChem Biosciences, Inc. (2023 - 2016)

Historical Annual Net Income of LegoChem Biosciences, Inc. (2023 - 2016)

Year	Net Income	Net Income Growth
2023	-73.7 Billion KRW	-63.45%
2022	-45.09 Billion KRW	-92.77%
2021	-23.39 Billion KRW	-234.82%
2020	-6.98 Billion KRW	-151.42%
2019	13.58 Billion KRW	152.72%
2018	-25.77 Billion KRW	-99.25%
2017	-12.93 Billion KRW	12.16%
2016	-14.72 Billion KRW	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-7.44 Billion KRW	-179.08%
2024 Q1	9.41 Billion KRW	158.29%
2023 Q1	-17.74 Billion KRW	30.41%
2023 Q2	-20.04 Billion KRW	-12.93%
2023 Q3	-19.76 Billion KRW	1.38%
2023 Q4	-16.15 Billion KRW	18.28%
2023 FY	-73.7 Billion KRW	-63.45%
2022 Q1	-8.5 Billion KRW	-158.97%
2022 FY	-45.09 Billion KRW	-92.77%
2022 Q3	-3.27 Billion KRW	58.09%
2022 Q2	-7.81 Billion KRW	8.09%
2022 Q4	-25.5 Billion KRW	-678.74%
2021 FY	-23.39 Billion KRW	-234.82%
2021 Q3	-8.76 Billion KRW	0.0%
2021 Q4	14.41 Billion KRW	264.46%
2020 FY	-6.98 Billion KRW	-151.42%
2019 FY	13.58 Billion KRW	152.72%
2018 FY	-25.77 Billion KRW	-99.25%
2017 FY	-12.93 Billion KRW	12.16%
2016 FY	-14.72 Billion KRW	0.0%

Peer Net Income Comparison of LegoChem Biosciences, Inc.

Name	Net Income	Net Income Difference
HLB Co., Ltd.	-189.07 Billion KRW	61.02%
iNtRON Biotechnology, Inc.	-9.69 Billion KRW	-660.19%
BINEX Co., Ltd.	4.67 Billion KRW	1677.982%
Bioneer Corporation	-10.58 Billion KRW	-596.169%
Anterogen.Co.,Ltd.	-2.84 Billion KRW	-2494.42%
MEDIPOST Co., Ltd.	5.83 Billion KRW	1362.048%
CrystalGenomics, Inc.	-48.92 Billion KRW	-50.65%
Helixmith Co., Ltd	-64.08 Billion KRW	-15.003%
Chabiotech Co.,Ltd.	-8.43 Billion KRW	-774.172%
Medy-Tox Inc.	9.75 Billion KRW	855.539%
Peptron, Inc.	-15.92 Billion KRW	-362.907%
Amicogen, Inc.	-23.28 Billion KRW	-216.475%
Genexine, Inc.	-66.87 Billion KRW	-10.213%
HLB Therapeutics Co.,Ltd.	-2.3 Billion KRW	-3101.499%
ALTEOGEN Inc.	-3.37 Billion KRW	-2085.905%
PharmaResearch Co., Ltd.	76.55 Billion KRW	196.28%
SillaJen, Inc.	-20.36 Billion KRW	-261.838%
JETEMA, Co., Ltd.	13.96 Billion KRW	627.739%
OliX Pharmaceuticals,Inc	-19.1 Billion KRW	-285.848%
Genomictree Inc.	-8.75 Billion KRW	-741.746%
MedPacto, Inc.	-35.32 Billion KRW	-108.645%
D&D Pharmatech	3.93 Billion KRW	1973.595%
EASY BIO,Inc.	15.54 Billion KRW	574.168%
GI Innovation, Inc.	-55.49 Billion KRW	-32.81%